foxo4 dri peptide senolytic 2023 study The disordered p53 transactivation domain is the target of and the compound FOXO4-DRI FOXO4-DRI regulates endothelial cell senescence
FOXO4 DRI regulates endothelial cell senescence via the P53 signaling pathway PMC FOXO4 DRI induces keloid senescent fibroblast apoptosis by promoting nuclear exclusion of upregulated p53 serine 15 phosphorylation Communications Biology FOXO4 DRI: Human Trial Status, Cancer Research & Senolytic Data Buy FOXO4 DRI (Proxofim) Senolytic Peptide For Cellular Renewal foxo4 dri peptide senolytic mouse study 2023 2024 Molecular modelling of the FOXO4 TP53 interaction to design peptides for the elimination of senescent cancer cells FOXO4 DRI Peptide for Cellular FOXO4 DRI Peptide Dosing Guide: Senolytic Peptide Protocol (June 2026)
Pay in 4 interest-free payments of $6.74 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Jul 30 - Aug 4





